![Michael Dambach](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Dambach
Treasurer en
BIOGEN INC.
.
Perfil
Michael E.
Dambach is currently Treasurer, Director & Vice President at Stromedix, Inc. and Treasurer & Vice President at Biogen, Inc. since 2010.
Former positions include Treasurer & Director at Bioverativ Therapeutics, Inc., Independent Director at BiomX, Inc. from 2023 to 2024, and Assistant Treasurer at Thermo Fisher Scientific, Inc. Education includes an MBA from Boston University and an undergraduate degree from the University of New Hampshire.
Cargos activos de Michael Dambach
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOGEN INC. | Treasurer | 01/01/2010 |
Stromedix, Inc.
 Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs to treat fibrosis and fibrotic organ failure | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Michael Dambach.
| Empresas | Cargo | Fin |
|---|---|---|
| BIOMX INC. | Director/Miembro de la Junta | 15/03/2024 |
| THERMO FISHER SCIENTIFIC, INC. | Corporate Officer/Principal | - |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Director/Miembro de la Junta | - |
Formación de Michael Dambach.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
78
Relaciones de 1er grado
7
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Stromedix, Inc.
Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs to treat fibrosis and fibrotic organ failure | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thermo Fisher Scientific, Inc.
 Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
BiomX, Inc.
 BiomX, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company developing natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin | Health Technology |
- Bolsa de valores
- Insiders
- Michael Dambach
